Aflaki E, Westbroek W, Sidransky E (2017) The complicated relationship between Gaucher disease and parkinsonism: insights from a rare disease. Neuron 93(4):737–746. https://doi.org/10.1016/j.neuron.2017.01.018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asakawa S, Abe I, Kudoh Y, Kishi N, Wang Y, Kubota R, Kudoh J, Kawasaki K, Minoshima S, Shimizu N (1997) Human BAC library: construction and rapid screening. Gene 191(1):69–79. https://doi.org/10.1016/s0378-1119(97)00044-9

Article  CAS  PubMed  Google Scholar 

Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, Berg-Alonso L, Kageyama Y, Serre V, Moore DG, Verschueren A, Rouzier C, Le Ber I, Auge G, Cochaud C, Lespinasse F, N’Guyen K, de Septenville A, Brice A, Yu-Wai-Man P, Sesaki H, Pouget J, Paquis-Flucklinger V (2014) A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137(Pt 8):2329–2345. https://doi.org/10.1093/brain/awu138

Article  PubMed  PubMed Central  Google Scholar 

Barodia SK, McMeekin LJ, Creed RB, Quinones EK, Cowell RM, Goldberg MS (2019) PINK1 phosphorylates ubiquitin predominantly in astrocytes. NPJ Parkinsons Dis 5:29. https://doi.org/10.1038/s41531-019-0101-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardoso F, Goetz CG, Mestre TA, Sampaio C, Adler CH, Berg D, Bloem BR, Burn DJ, Fitts MS, Gasser T, Klein C, de Tijssen MAJ, Lang AE, Lim SY, Litvan I, Meissner WG, Mollenhauer B, Okubadejo N, Okun MS, Postuma RB, Svenningsson P, Tan LCS, Tsunemi T, Wahlstrom-Helgren S, Gershanik OS, Fung VSC, Trenkwalder C (2023) A statement of the MDS on biological definition, staging, and classification of Parkinson’s disease. Mov Disord. https://doi.org/10.1002/mds.29683

Article  PubMed  Google Scholar 

Castelo Rueda MP, Zanon A, Gilmozzi V, Lavdas AA, Raftopoulou A, Delcambre S, Del Greco MF, Klein C, Grunewald A, Pramstaller PP, Hicks AA, Pichler I (2023) Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers. NPJ Parkinsons Dis 9(1):65. https://doi.org/10.1038/s41531-023-00499-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cossu D, Yokoyama K, Sato S, Noda S, Sechi LA, Hattori N (2021) PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol 359:577694. https://doi.org/10.1016/j.jneuroim.2021.577694

Article  CAS  PubMed  Google Scholar 

Daida K, Funayama M, Billingsley KJ, Malik L, Miano-Burkhardt A, Leonard HL, Makarious MB, Iwaki H, Ding J, Gibbs JR, Ishiguro M, Yoshino H, Ogaki K, Oyama G, Nishioka K, Nonaka R, Akamatsu W, Blauwendraat C, Hattori N (2023) Long-read sequencing resolves a complex structural variant in PRKN Parkinson’s disease. Mov Disord 38(12):2249–2257. https://doi.org/10.1002/mds.29610

Article  CAS  PubMed  Google Scholar 

Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, Li Y, Ogaki K, Ando M, Yoshino H, Tomiyama H, Nishioka K, Hasegawa K, Saiki H, Satake W, Mogushi K, Sasaki R, Kokubo Y, Kuzuhara S, Toda T, Mizuno Y, Uchiyama Y, Ohno K, Hattori N (2015) CHCHD2 mutations in autosomal dominant late-onset Parkinson’s disease: a genome-wide linkage and sequencing study. Lancet Neurol 14(3):274–282. https://doi.org/10.1016/S1474-4422(14)70266-2

Article  CAS  PubMed  Google Scholar 

Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H, Kobayashi T, Yokochi M, Wang M, Yoritaka A, Kondo T, Kuzuhara S, Nakamura S, Shimizu N, Mizuno Y (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44(6):935–941. https://doi.org/10.1002/ana.410440612

Article  CAS  PubMed  Google Scholar 

He Y, Kaya I, Shariatgorji R, Lundkvist J, Wahlberg LU, Nilsson A, Mamula D, Kehr J, Zareba-Paslawska J, Biverstal H, Chergui K, Zhang X, Andren PE, Svenningsson P (2023) Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents. Nat Commun 14(1):5804. https://doi.org/10.1038/s41467-023-41539-5

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S, Klein C (2002) Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutations. Neurology 58(8):1239–1246. https://doi.org/10.1212/wnl.58.8.1239

Article  CAS  PubMed  Google Scholar 

Hristova VA, Beasley SA, Rylett RJ, Shaw GS (2009) Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. J Biol Chem 284(22):14978–14986. https://doi.org/10.1074/jbc.M808700200

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ikeda A, Matsushima T, Daida K, Nakajima S, Conedera S, Li Y, Yoshino H, Oyama G, Funayama M, Nishioka K, Hattori N (2017) A novel mutation of CHCHD2 p. R8H in a sporadic case of Parkinson’s disease. Parkinsonism Relat Disord 34:66–68. https://doi.org/10.1016/j.parkreldis.2016.10.018

Article  PubMed  Google Scholar 

Ikeda A, Nishioka K, Meng H, Takanashi M, Hasegawa I, Inoshita T, Shiba-Fukushima K, Li Y, Yoshino H, Mori A, Okuzumi A, Yamaguchi A, Nonaka R, Izawa N, Ishikawa KI, Saiki H, Morita M, Hasegawa M, Hasegawa K, Elahi M, Funayama M, Okano H, Akamatsu W, Imai Y, Hattori N (2019) Mutations in CHCHD2 cause alpha-synuclein aggregation. Hum Mol Genet 28(23):3895–3911. https://doi.org/10.1093/hmg/ddz241

Article  CAS  PubMed  Google Scholar 

Ikeda A, Imai Y, Hattori N (2022) Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two? Front Cell Dev Biol 10:996061. https://doi.org/10.3389/fcell.2022.996061

Article  PubMed  PubMed Central  Google Scholar 

Kano M, Takanashi M, Oyama G, Yoritaka A, Hatano T, Shiba-Fukushima K, Nagai M, Nishiyama K, Hasegawa K, Inoshita T, Ishikawa KI, Akamatsu W, Imai Y, Bolognin S, Schwamborn JC, Hattori N (2020) Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations. NPJ Parkinsons Dis 6(1):33. https://doi.org/10.1038/s41531-020-00137-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan NL, Graham E, Critchley P, Schrag AE, Wood NW, Lees AJ, Bhatia KP, Quinn N (2003) Parkin disease: a phenotypic study of a large case series. Brain 126(Pt 6):1279–1292. https://doi.org/10.1093/brain/awg142

Article  PubMed  Google Scholar 

Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605–608. https://doi.org/10.1038/33416

Article  ADS  CAS  PubMed  Google Scholar 

Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, Sou YS, Saiki S, Kawajiri S, Sato F, Kimura M, Komatsu M, Hattori N, Tanaka K (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189(2):211–221. https://doi.org/10.1083/jcb.200910140

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumine H, Saito M, Shimoda-Matsubayashi S, Tanaka H, Ishikawa A, Nakagawa-Hattori Y, Yokochi M, Kobayashi T, Igarashi S, Takano H, Sanpei K, Koike R, Mori H, Kondo T, Mizutani Y, Schaffer AA, Yamamura Y, Nakamura S, Kuzuhara S, Tsuji S, Mizuno Y (1997) Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2–27. Am J Hum Genet 60(3):588–596

CAS  PubMed  PubMed Central  Google Scholar 

Matsumine H, Yamamura Y, Hattori N, Kobayashi T, Kitada T, Yoritaka A, Mizuno Y (1998) A microdeletion of D6S305 in a family of autosomal recessive juvenile parkinsonism (PARK2). Genomics 49(1):143–146. https://doi.org/10.1006/geno.1997.5196

Article  CAS  PubMed  Google Scholar 

Meng H, Yamashita C, Shiba-Fukushima K, Inoshita T, Funayama M, Sato S, Hatta T, Natsume T, Umitsu M, Takagi J, Imai Y, Hattori N (2017) Loss of Parkinson’s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Nat Commun 8:15500. https://doi.org/10.1038/ncomms15500

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Mitsui J, Takahashi Y, Goto J, Tomiyama H, Ishikawa S, Yoshino H, Minami N, Smith DI, Lesage S, Aburatani H, Nishino I, Brice A, Hattori N, Tsuji S (2010) Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am J Hum Genet 87(1):75–89. https://doi.org/10.1016/j.ajhg.2010.06.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mori H, Kondo T, Yokochi M, Matsumine H, Nakagawa-Hattori Y, Miyake T, Suda K, Mizuno Y (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 51(3):890–892. https://doi.org/10.1212/wnl.51.3.890

Article  CAS  PubMed  Google Scholar 

Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183(5):795–803. https://doi.org/10.1083/jcb.200809125

Article  PubMed  PubMed Central  Google Scholar 

Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8(1):e1000298. https://doi.org/10.1371/journal.pbio.1000298

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nicoletti G, Gagliardi M, Procopio R, Iannello G, Morelli M, Annesi G, Quattrone A (2018) A new CHCHD2 mutation identified in a southern Italy patient with multiple system atrophy. Parkinsonism Relat Disord 47:91–93. https://doi.org/10.1016/j.parkreldis.2017.12.005

Article  PubMed  Google Scholar